Aurora Mobile Limited, a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary Wuhan SendCloud Technology Co., Ltd. (“SendCloud”) has entered into a strategic partnership with Kingyee (Beijing) Co., Ltd., an indirect wholly-owned subsidiary of Medlive Technology Co., Ltd. which operates the medical service platform Medlive. Leveraging its cutting-edge email technology, SendCloud will provide the Medlive platform with high-efficiency email services. This cooperation is another validation of the industry-wide acclaim and trust that SendCloud commands for the high-quality services it offers to medical service providers.

Launched on August 8, 2006, the Medlive platform focuses on providing medical information services to support physicians’ clinical decision-making in China, covering medical information, case data, medical knowledge base, clinical guidelines, drug inquiry, medical video courses and other services. It has more than 3 million registered users and has developed into a professional platform widely trusted by Chinese physicians.

Marketing Technology News: Conduent Customer Experience Management Data Analysis: Technology Consumers Remain in Chat Channel

Aurora Mobile is a leading provider of customer engagement and marketing technology services in China. Since its inception, Aurora Mobile has focused on providing stable and efficient messaging services to enterprises and has grown to be a leading mobile messaging service provider with its first-mover advantage. With the increasing demand for customer reach and marketing growth, Aurora Mobile has developed forward-looking solutions such as Cloud Messaging and Cloud Marketing to help enterprises achieve omnichannel customer reach and interaction, as well as artificial intelligence and big data-driven marketing technology solutions to help enterprises’ digital transformation.

Marketing Technology News: MarTech Interview with James Shears, Senior Vice President and General Manager at BLOCKBOARD